Targeted therapies are a class of anticancer drugs designed to specifically target molecular pathways critical for cancer cell survival and proliferation. Unlike traditional chemotherapy, which affects both cancerous and normal cells, targeted therapies aim to minimize damage to healthy tissues. Monoclonal antibodies and tyrosine kinase inhibitors are examples of targeted therapies.
